
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
HspBP1 CRISPR/Cas9 KO Plasmid (h) | sc-406487 | 20 µg | $397.00 |
HSPBP1 encodes HspBP1, a nucleotide exchange factor and co-chaperone that regulates the HSP70/HSC70 chaperone cycle by modulating ATP/ADP exchange and client release. Through its interactions with molecular chaperones, HspBP1 contributes to proteostasis, stress response signaling, and the quality control of misfolded or damaged proteins that may otherwise accumulate and perturb cellular homeostasis. Dysregulation of chaperone networks, including HSP70 cofactor balance, is frequently linked to altered protein turnover and stress tolerance in contexts such as neurodegeneration and cancer biology, making HSPBP1 a useful node for mechanistic studies. In human cells, perturbing HspBP1 can help define how chaperone-assisted folding intersects with protein degradation pathways and stress-adaptive remodeling.
HspBP1 CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the HSPBP1 gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the HSPBP1 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the HSPBP1 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish HspBP1 protein expression.
This CRISPR knockout system enables efficient generation of HSPBP1-deficient cell models for investigation of HspBP1 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.